RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-842
Malaria parasiteP. yoelii
Genotype
DisruptedGene model (rodent): PY17X_0719200; Gene model (P.falciparum): PF3D7_0417100; Gene product: mRNA-binding protein PUF2 (Pumilio2)
Phenotype Sporozoite; Liver stage;
Last modified: 14 March 2013, 17:07
  *RMgm-842
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 23356439
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. yoelii
Parent strain/lineP. y. yoelii 17XNL
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherLindner SE; Kappe SH
Name Group/DepartmentSeattle Biomedical Research Institute
Name InstituteSeattle Biomedical Research Institute
CitySeattle
CountryUS
Name of the mutant parasite
RMgm numberRMgm-842
Principal namepypuf2-
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNormal numbers of salivary gland sporozoites.
Sporozoites progressively lost infectivity after arrival in the salivary glands, becoming non-infectious within the following 8 days. A significant and progressively increasing fraction of sporozoites prematurely transformed inside the salivary glands into forms that resemble young liver stages
Liver stageNormal numbers of salivary gland sporozoites.
Sporozoites progressively lost infectivity after arrival in the salivary glands, becoming non-infectious to mice within the following 8 days.
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of the RNA binding protein Puf2.

Protein (function)
The roles of Puf (Pumilio and fem-3 mRNA binding factor) proteins are diverse yet intimately involved in the translational regulation of developmental and differentiation factors in organisms as diverse as yeast, C. elegans, Drosophila and humans. Two such proteins, Puf1 (PFE0935c) and Puf2 (PFD0825c), are known in the human malaria parasite, P. falciparum, with orthologs in all Plasmodium spp. characterized. The Plasmodium Puf proteins have the typical highly conserved organization that includes the eight tandem copies of the PUM RNA binding domain (or Pumilio Homology Domain, PHD) at the carboxyterminus of the protein and expectedly PfPuf2 was shown to bind RNA in vitro. In P. falciparum evidence has been reported for a role for Puf2 in gametocyte development although Pfpuf2 is most highly transcribed in sporozoites

Phenotype
The phenotype analyses indicate that Puf2 is not essential for blood stage development, production of gametocytes, ookinetes, oocysts and  sporozoites. However, sporozoite infectivity is affected. A significant and progressively increasing fraction of sporozoites prematurely transformed inside the salivary glands into forms that resemble young liver stages. The phenotype described for Pypuf2- sporozoites is comparable to P. berghei sporozoites that lack expression of Puf2 (see
RMgm-515, RMgm-516, RMgm-617), although also differences were detected. The phenotype analyses indicate that Puf2 regulates the transition of sporozoites into liver stage forms.

Additional information
The phenotype analyses indicate that the RNA binding protein Puf2 regulates the transition of sporozoites into liver stage forms and allows the sporozoite to remain infectious in the salivary glands while awaiting transmission, likely by stabilizing or hastening the degradation of specific mRNAs.
Through analysis of a mutant that expresses a mutated form of Puf2 (see RMgm-843) evidence is presented that only the RNA binding domain (RBD) is essential for its function.
By analysis of the location of Puf2 in sporozoites evidence is presented that Puf2 traffics to sporozoite cytosolic granules, which are negative for several markers of stress granules and P-bodies, and disappear rapidly after infection of hepatocytes.
RNAseq analyses provided evidence for a role of Puf2 in directly or indirectly maintaining the homeostasis of specific transcripts in sporozoites.

Other mutants
P. berghei mutants that lack expression of PuF2: RMgm-515, RMgm-516, RMgm-617)
RMgm-843: a P. yoelii mutant expressing a mutated form of Puf2


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PY17X_0719200
Gene Model P. falciparum ortholog PF3D7_0417100
Gene productmRNA-binding protein PUF2
Gene product: Alternative namePumilio2
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct usedPlasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationGene targeting constructs for transgenic parasite production were designed as previously described with some modifications (Mikolajczak et al., 2008a). Briefly, two regions of the targeted locus were PCR amplified. The two PCR products were fused by Sequence Overlap Extension PCR (“SOE PCR”) by virtue of complementary sequences designed into the primers. This SOE PCR product (“targeting sequence”) was digested at the 5’ and 3’ ends via exogenous restriction sites designed in the primers and inserted into a modified pDEF vector designed for genetic disruptions or for gene modifications by locus replacement via double-crossover recombination. Prior to transfection, plasmids were linearized at unique restriction sites designed between the two halves of the targeting sequences
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1CCGAATTCCATGTACATGTGCATACAAAAAGTGGACACACTTGTATG
Additional information primer 13'-Fwd
Sequence Primer 2GCTAGTTATGGGGCCCAGCTAGCGTGTGTATGTATGCATGTATGTAGAGAGGGAAATG
Additional information primer 23'-Rev (SOE)
Sequence Primer 3CACACGCTAGCTGGGCCCCATAACTAGCAAAATAGCGAAATGACATAACAAAACGACAAC
Additional information primer 35'-Fwd (SOE)
Sequence Primer 4GGCCGCGGGGTTGTACATGTATATATATTACATATGATTAGAAAATATGAACAAGG
Additional information primer 45'-Rev
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6